Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 22 of 37
Newsletters
How Pfizer’s COVID vaccine technology could help tame new coronavirus strains
By
Sy Mukherjee
February 25, 2021
Health
After just one dose of the Pfizer-BioNTech vaccine, hospitalizations are down 92%, Israeli study shows
By
Naomi Kresge
,
Jason Gale
and
Bloomberg
February 25, 2021
Health
How states are doing in the COVID vaccine rollout: Storm-battered Texas falls behind
By
Erika Fry
and
Nicolas Rapp
February 25, 2021
Health
Pfizer’s competitors are lining up to make its COVID-19 vaccine
By
Chris Morris
February 23, 2021
Health
Pfizer’s extra vaccine dose was supposed to be a miracle. It’s now a mess
By
David Z. Morris
February 21, 2021
Health
As mutant COVID variants multiply, the hunt is on for a ‘universal’ kill-all vaccine
By
Jeremy Kahn
February 19, 2021
Health
The Pfizer COVID vaccine is more durable than we thought—and highly effective after one dose
By
David Z. Morris
February 19, 2021
Health
How each U.S. state is doing in the COVID vaccine rollout
By
Erika Fry
and
Nicolas Rapp
February 18, 2021
Health
What you need to know about severe reactions to COVID vaccines
By
John Lauerman
,
Jason Gale
and
Bloomberg
February 15, 2021
Health
Iceland wants Pfizer to conduct a nationwide COVID-19 study. There’s just one problem: it has too few cases.
By
Kristen V. Brown
,
Ragnhildur Sigurdardottir
and
Bloomberg
February 15, 2021
Health
How each U.S. state is doing when it comes to COVID vaccine distribution
By
Erika Fry
and
Nicolas Rapp
February 11, 2021
Health
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By
Riley Griffin
and
Bloomberg
February 10, 2021
Health
J&J’s COVID vaccine could make its global debut as soon as next week
By
David Meyer
February 10, 2021
Health
The AstraZeneca COVID-19 vaccine (and possibly others) are ineffective against the South African variant
By
Jeremy Kahn
February 8, 2021
Health
How to stop vaccine nationalism from prolonging the pandemic
By
David Meyer
February 7, 2021
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By
Sasha Rogelberg
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By
Nick Lichtenberg
Economy
Gen Z’s straight‑A boom is quietly shrinking their paychecks
By
Jake Angelo